Table of Content




1. Executive Summary


2. Global 3D Bioprinting Market: Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges


3. Market Trends and Forecast Analysis from 2017 to 2028
3.1: Macroeconomic Trends (2017-2022) and Forecast (2023-2028)
3.2: Global 3D Bioprinting Market Trends (2017-2022) and Forecast (2023-2028)
3.3: Global 3D Bioprinting Market by Technology
3.3.1: Magnetic 3D Bioprinting
3.3.2: Laser-assisted Bioprinting
3.3.3: Inkjet 3D Bioprinting
3.3.4: Microextrusion 3D Bioprinting
3.3.5: Methyl Mercaptan Sensors
3.3.6: Others
3.4: Global 3D Bioprinting Market by Product
3.4.1: 3D Bioprinters
3.4.2: Biomaterials
3.4.3: Scaffolds
3.5: Global 3D Bioprinting Market by Material
3.5.1: Living Cells
3.5.2: Extracellular Matrices
3.5.3: Hydrogels
3.5.4: Others
3.6: Global 3D Bioprinting Market by Application
3.6.1: Clinical Applications
3.6.2: Skin
3.6.3: Bones
3.6.4: Blood Vessels
3.6.5: Research Applications
3.6.6: Drug and Medical Research
3.6.7: Regenerative Medicine
3.6.8: 3D Cell Culture
3.7: Global 3D Bioprinting Market by End Use Industry
3.7.1: Pharmaceutical & Biotechnology Companies
3.7.2: Research Organizations & Academic Institutes
3.7.3: Others


4. Market Trends and Forecast Analysis by Region from 2017 to 2028
4.1: Global 3D Bioprinting Market by Region
4.2: North American 3D Bioprinting Market
4.2.1: North American 3D Bioprinting Market by Product: 3D Bioprinters, Biomaterials, and Scaffolds
4.2.2: North American 3D Bioprinting Market by End Use Industry: Pharmaceutical & Biotechnology, Research Organizations & Academic Institutes, and Others
4.3: European 3D Bioprinting Market
4.3.1: European 3D Bioprinting Market by Product: 3D Bioprinters, Biomaterials, and Scaffolds
4.3.2: European 3D Bioprinting Market by End Use Industry: Pharmaceutical & Biotechnology, Research Organizations & Academic Institutes, and Others
4.4: APAC 3D Bioprinting Market
4.4.1: APAC 3D Bioprinting Market by Product: 3D Bioprinters, Biomaterials, and Scaffolds
4.4.2: APAC 3D Bioprinting Market by End Use Industry: Pharmaceutical & Biotechnology, Research Organizations & Academic Institutes, and Others
4.5: ROW 3D Bioprinting Market
4.5.1: ROW 3D Bioprinting Market by Product: 3D Bioprinters, Biomaterials, and Scaffolds
4.5.2: ROW 3D Bioprinting Market by End Use Industry: Pharmaceutical & Biotechnology, Research Organizations & Academic Institutes, and Others


5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis


6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global 3D Bioprinting Market by Technology
6.1.2: Growth Opportunities for the Global 3D Bioprinting Market by Product
6.1.3: Growth Opportunities for the Global 3D Bioprinting Market by Material
6.1.4: Growth Opportunities for the Global 3D Bioprinting Market by Application
6.1.5: Growth Opportunities for the Global 3D Bioprinting Market by End Use Industry
6.1.6: Growth Opportunities for the Global 3D Bioprinting Market by Region
6.2: Emerging Trends in the Global 3D Bioprinting Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global 3D Bioprinting Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global 3D Bioprinting Market
6.3.4: Certification and Licensing


7. Company Profiles of Leading Players
7.1: Organovo Holdings
7.2: Envisiontec
7.3: Nano 3D Biosciences
7.4: Cyfuse Biomedical
7.5: Regenhu